Home › Peanut Hypersensitivity › California
Peanut Hypersensitivity clinical trials in California
4 studies for Peanut Hypersensitivity are looking for participants at sites in California.
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
- California Allergy and Asthma Medical Group, Los Angeles
RecruitingPhase 3
Ages 12 to 65 · All sexes · Updated Sep 25, 2026 · NCT07768371Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- University of California, Los Angeles: Department of Medicine, Division of Clinical Immunology and Allergy, Los Angeles
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Sep 16, 2026 · NCT07015996Study of Oral Food Challenge Biomarkers (SAFER)
- Stanford School of Medicine: Sean N. Parker Center for Allergy & Asthma Research, Palo Alto
RecruitingObservational study
12 Months – 17 Years · All sexes · Updated Sep 9, 2026 · NCT07279467Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- Sean N. Parker Center for Allergy and Asthma Research, Palo Alto
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Jul 28, 2026 · NCT07220811From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.